{
    "2018-02-02": [
        [
            {
                "time": "2018-02-07",
                "original_text": "Novartis’s 4Q17 Earnings: Innovative Medicines Business",
                "features": {
                    "keywords": [
                        "Novartis",
                        "4Q17",
                        "Innovative Medicines",
                        "Earnings"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-02-07",
                "original_text": "Biogen’s Tecfidera and Tysabri: 4Q17 Performance",
                "features": {
                    "keywords": [
                        "Biogen",
                        "Tecfidera",
                        "Tysabri",
                        "4Q17",
                        "Performance"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-02-07",
                "original_text": "Novartis’s 4Q17 Earnings: Segment-Wise Revenues",
                "features": {
                    "keywords": [
                        "Novartis",
                        "4Q17",
                        "Segment-Wise",
                        "Revenues"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-02-07",
                "original_text": "Novartis’s 4Q17 Revenues and Fiscal 2017 Revenues",
                "features": {
                    "keywords": [
                        "Novartis",
                        "4Q17",
                        "Revenues",
                        "Fiscal 2017"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-02-07",
                "original_text": "Biogen: How It Performed in 4Q17",
                "features": {
                    "keywords": [
                        "Biogen",
                        "4Q17",
                        "Performance"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-02-07",
                "original_text": "Amgen (AMGN) Q4 Earnings & Sales Lag, 2018 Sales View Soft",
                "features": {
                    "keywords": [
                        "Amgen",
                        "Q4",
                        "Earnings",
                        "Sales",
                        "Lag",
                        "2018",
                        "Soft"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-02-07",
                "original_text": "AstraZeneca: Analyst Ratings and Recommendations",
                "features": {
                    "keywords": [
                        "AstraZeneca",
                        "Analyst Ratings",
                        "Recommendations"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-02-07",
                "original_text": "Is a Beat in the Cards for Glaxo (GSK) This Earnings Season?",
                "features": {
                    "keywords": [
                        "Glaxo",
                        "GSK",
                        "Earnings",
                        "Season",
                        "Beat"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-02-07",
                "original_text": "Cell Therapy Market Could Boost Celgene’s Long-Term Growth",
                "features": {
                    "keywords": [
                        "Cell Therapy",
                        "Market",
                        "Celgene",
                        "Long-Term",
                        "Growth"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-02-07",
                "original_text": "AstraZeneca’s 4Q17 Estimates: Segment Revenues",
                "features": {
                    "keywords": [
                        "AstraZeneca",
                        "4Q17",
                        "Estimates",
                        "Segment",
                        "Revenues"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-02-07",
                "original_text": "Celgene: Pomalyst and Otezla’s Revenue Trends in 4Q17",
                "features": {
                    "keywords": [
                        "Celgene",
                        "Pomalyst",
                        "Otezla",
                        "Revenue",
                        "Trends",
                        "4Q17"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-02-07",
                "original_text": "AstraZeneca’s 4Q17 Earnings: Analyst Estimates",
                "features": {
                    "keywords": [
                        "AstraZeneca",
                        "4Q17",
                        "Earnings",
                        "Analyst",
                        "Estimates"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-02-07",
                "original_text": "How Has Johnson & Johnson Stock Performed Recently?",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "Stock",
                        "Performed",
                        "Recently"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-02-07",
                "original_text": "The Swiss Stock Market Extends Losing Streak",
                "features": {
                    "keywords": [
                        "Swiss",
                        "Stock Market",
                        "Losing Streak"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "market"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}